Selected article for: "Arbidol group and control group"
Author: Yueping Li; Zhiwei Xie; Weiyin Lin; Weiping Cai; Chunyan Wen; Yujuan Guan; Xiaoneng Mo; Jian Wang; Yaping Wang; Ping Peng; Xudan Chen; Wenxin Hong; Guangming Xiao; Jinxin Liu; Lieguang Zhang; Fengyu Hu; Feng Li; Feng Li; Fuchun Zhang; Xilong Deng; Linghua Li
Title: An exploratory randomized, controlled study on the efficacy and safety of lopinavir/ritonavir or arbidol treating adult patients hospitalized with mild/moderate COVID-19 (ELACOI)
  • Document date: 2020_3_23
    • ID: 9hknw4ws_57
    Snippet: The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.19.20038984 doi: medRxiv preprint author/funder, who has granted medRxiv a license to display the preprint in perpetuity. author/funder, who has granted medRxiv a license to display the preprint in perpetuity. hypertension and 2 with both in the LPV/r group; one patient with Coronary Heart Disease, 3 hypertension and 1 chronic liver disea.....
    Document: The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.19.20038984 doi: medRxiv preprint author/funder, who has granted medRxiv a license to display the preprint in perpetuity. author/funder, who has granted medRxiv a license to display the preprint in perpetuity. hypertension and 2 with both in the LPV/r group; one patient with Coronary Heart Disease, 3 hypertension and 1 chronic liver disease in the arbidol group; and one patient with Coronary Heart Disease, 2 hypertension, 2 chronic liver disease and 1 with both diabetes and chronic liver disease in the control group.

    Search related documents:
    Co phrase search for related documents
    • chronic liver disease and control group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • chronic liver disease and control group chronic liver disease diabetes: 1
    • chronic liver disease and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • chronic liver disease diabetes and control group: 1, 2
    • chronic liver disease diabetes and control group chronic liver disease diabetes: 1
    • chronic liver disease diabetes and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • control group and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • control group chronic liver disease diabetes and liver disease: 1
    • Coronary Heart Disease patient and liver disease: 1